Related Experiment Videos
Monosymptomatic hypochondriacal psychosis: a diagnostic checklist based on 50 cases of the disorder
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Baseline Neurocognitive Functioning in Children/Teenagers and Young Adults Treated for Central Nervous System Malignancies Prior to Proton Therapy.
Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Maternal respiratory distress and successful reversal with sugammadex during intrauterine transfusion with fetal paralysis.
International journal of obstetric anesthesia·2019
Risk of persistent or recurrent cervical neoplasia in patients with 'pure' adenocarcinoma-in-situ (AIS) or mixed AIS and high-grade cervical squamous neoplasia (cervical intra-epithelial neoplasia grades 2 and 3 (CIN 2/3)): a population-based study.
BJOG : an international journal of obstetrics and gynaecology·2017
The impact of human papillomavirus type on colposcopy performance in women offered HPV immunisation in a catch-up vaccine programme: a two-centre observational study.
BJOG : an international journal of obstetrics and gynaecology·2017
Investigation of the Gut Microbiome in Treatment-Resistant Schizophrenia Compared to Healthy Controls: A Cross-Sectional Pilot Study: Étude du microbiome intestinal chez les patients atteints de schizophrénie résistante au traitement par rapport aux témoins sains : étude pilote transversale.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Metformin, but Not Aripiprazole, Was Associated With Attenuation of Weight Gain in Clozapine-Treated Inpatients With Concurrent Disorders: A Repeated Measures Cohort Analysis: La metformine, mais non l'aripiprazole, a été associée à une atténuation du gain de poids chez les patients hospitalisés traités par la clozapine et présentant des troubles concomitants : une analyse de cohorte à mesures répétées.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Pharmacological Management of Opioid Use Disorder: A Systematic Review and Network Meta-Analysis: Prise en charge pharmacologique du trouble de l'usage des opiacés : revue systématique et méta-analyse en réseau.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Adherence and Acceptability of Smartphone- and Wearable-Based Digital Phenotyping in Patients With First-Episode Psychosis: Observance et acceptabilité du phénotypage numérique fondé sur les téléphones intelligents et les objets personnels connectés chez les patients présentant un premier épisode de psychose.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Cannabis Use Interacts With Psychosis Vulnerability in Borderline Personality Disorder: La consommation de cannabis interagit avec la vulnérabilité à la psychose dans le trouble de la personnalité limite.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
A Multivariate Approach to Communication Impoverishment and Cognitive Performance in Treatment-Resistant Schizophrenia: Analyse à plusieurs variables portant sur l'appauvrissement de la communication et la performance cognitive dans les cas de schizophrénie résistante au traitement.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Sex differences in alcohol and amphetamine-like compound consumption and their relationship with mu opioid receptor density in the pallidal-mesolimbic system.
Pharmacology, biochemistry, and behavior·2026
Ayahuasca treatment reduces 50-kHz ultrasonic vocalizations and modifies mesocorticolimbic monoamine neurochemistry in rats.
Pharmacology, biochemistry, and behavior·2026
Systematic identification of p11 as a signaling modulator across the GPCRome.
Science advances·2026
Paraventricular Hypothalamic GLP-1R Neurons Mediate Propofol-Induced Suppression of Food Intake.
Journal of integrative neuroscience·2026
Anxiolytic and antidepressant effects of 1-phenyl-1-propanol-mediated bile acids in a chronic unpredictable mild stress mouse model.
International immunopharmacology·2026